TY - JOUR
T1 - Microwave-assisted synthesis of tubulin assembly inhibitors as anticancer agents by aryl ring reversal and conjunctive approach
AU - Masci, Domiziana
AU - Puxeddu, Michela
AU - Colla, Claudia
AU - Coluccia, Antonio
AU - Santelli, Martina
AU - Sciò, Pietro
AU - Mariotto, Elena
AU - Viola, Giampietro
AU - Hamel, Ernest
AU - Lerose, Rosa
AU - Mazzoccoli, Carmela
AU - Silvestri, Romano
AU - La Regina, Giuseppe
PY - 2025
Y1 - 2025
N2 - Microwave-assisted synthesis of new pyrrole and indole derivatives as tubulin assembly inhibitors was performed with remarkably improved yields and short reaction times. In designing the new inhibitors, aryl ring reversal and conjunctive approach notions were applied. (4-(4-Methoxyphenyl)-1-(pyridin-2-yl)-1H-pyrrol-3-yl)(3,4,5-trimethoxyphenyl) methanone (4) inhibited [3H] colchicine binding by 78% and MCF-7 breast cancer cell growth with an IC50 of 9.6 nM. Compound 4 also inhibited the growth of HCT116, BX-PC3 and Jurkat cancer cells with IC50 values of 18, 17 and 41 nM, respectively, and altered the morphology of treated spheroids in both the BX-PC3 and HCT116 cell lines.
AB - Microwave-assisted synthesis of new pyrrole and indole derivatives as tubulin assembly inhibitors was performed with remarkably improved yields and short reaction times. In designing the new inhibitors, aryl ring reversal and conjunctive approach notions were applied. (4-(4-Methoxyphenyl)-1-(pyridin-2-yl)-1H-pyrrol-3-yl)(3,4,5-trimethoxyphenyl) methanone (4) inhibited [3H] colchicine binding by 78% and MCF-7 breast cancer cell growth with an IC50 of 9.6 nM. Compound 4 also inhibited the growth of HCT116, BX-PC3 and Jurkat cancer cells with IC50 values of 18, 17 and 41 nM, respectively, and altered the morphology of treated spheroids in both the BX-PC3 and HCT116 cell lines.
KW - Anticancer agents
KW - Heterocyclic compounds
KW - Microwave-assisted synthesis
KW - Green Chemistry
KW - Anticancer agents
KW - Heterocyclic compounds
KW - Microwave-assisted synthesis
KW - Green Chemistry
UR - https://publicatt.unicatt.it/handle/10807/323897
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=105018766780&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105018766780&origin=inward
U2 - 10.1039/d5md00406c
DO - 10.1039/d5md00406c
M3 - Article
SN - 2040-2503
VL - 16
SP - 4845
EP - 4858
JO - RSC Medicinal Chemistry
JF - RSC Medicinal Chemistry
IS - 10
ER -